Intracranial aneurysms in sickle cell disease: Aneurysms characteristics and modalities of endovascular approach to treat these patients.
Cerebral aneurysms
Sickle cell disease
Thromboembolic complications
Journal
Journal of neuroradiology = Journal de neuroradiologie
ISSN: 0150-9861
Titre abrégé: J Neuroradiol
Pays: France
ID NLM: 7705086
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
23
11
2015
revised:
12
03
2019
accepted:
13
03
2019
pubmed:
25
3
2019
medline:
17
3
2021
entrez:
25
3
2019
Statut:
ppublish
Résumé
The neurological complications of Sickle Cell Disease (SCD) include cerebral infarction and haemorrhage with rarely subarachnoid haemorrhage due to cerebral aneurysms. In our interventional department, working with SCD referral department, we reported our experience concerning management of adult's patients with cerebral aneurysms. We identified 26 adults with 48 intracranial aneurysms documented by imaging. 18 patients, with 26 cerebral aneurysms were treated by endovascular approach for their aneurysms. No patient was treated by surgical way in our institution. 50% of patients had multiple aneurysms. Locations of aneurysms treated were typical with 70% of cerebral anterior artery and 30% of posterior artery. Three patients suffered from subarachnoid haemorrhage. Two procedure-related complications occurred during the treatment: one thrombo-embolic event with good recovery after medical treatment and one aneurismal perforation leading to the death of patient. Hypercoagulability is a major specific risk in SCD and use of permanent device as stent of flow diverter should be discussed to prevent complications. Endovascular management of these aneurysms seems to be a good alternative to treat these patients, with stability of occlusion at follow-up.
Identifiants
pubmed: 30904450
pii: S0150-9861(19)30200-7
doi: 10.1016/j.neurad.2019.03.001
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
221-226Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.